A novel elastase inhibitor from Aspergillus nidulans NBRC 4340, Asnidin, was isolated, and biochemical properties and partial amino acid sequence were examined. Column chromatography using diethylaminoethyl（DE）52-Cellulose and reversed-phase HPLC were used to purify the inhibitor. Purified Asnidin was found to be homogeneous as indicated by reversed-phase HPLC and TOF-MS （Time of Flight Mass Spectrometry） . Asnidin has a molecular weight of 4,181.63 as determined by TOF-MS. The elastolytic activities of elastases from A. fumigatus, A. flavus, and human leukocytes but not chymotrypsin, and elastases from snake venom and bacteria were inhibited by Asnidin. The fibrinogenase and collagen type IV hydrolytic activities of the elastase from A. fumigatus were inhibited by Asnidin. Asnidin was found to be stable under heat treatment and over a wide pH range. The elastolytic inhibitory activity of Asnidin was inhibited by dithiothreitol（DTT） , while no inhibition was observed with ethylenediaminetetraacetic acid（EDTA-2Na）and benzamidine. Since there is a possibility of Asnidin becoming another drug in the arsenal of weapons against aspergillosis or interstitial pneumonia, further studies are warranted.
Introduction
Aspergillosis infection is most likely to occur in immuno-compromised patients, is showing a tendency to increase in recent years, and is a most common important infection ranked with candidosis as fungal infection. It is caused by inhalation of high spore concentrations of the Aspergillus species. It is reported that various proteases are produced from A. fumigatus 1−6） , A. flavus 7, 8） and A. niger 9−11） .
Elastase-producing strains destroy lung tissue 12, 13） and an elastase produced by Aspergillus is confirmed as a definitive virulence factor of aspergillosis 14−17） . Hasegawa et al. 2） purified an elastase from A. fumigatus and proved the pathogenicity of elastase. The aim of this research is to develop a drug for treatment of aspergillosis and acute respiratory distress syndrome（ARDS） . It has been shown that A. fumigatus and A. flavus produced elastase inhibitors 18） , and the respective elastase inhibitors were isolated from these Aspergillus strains 19−22） . In this paper, we report the isolation and biochemical properties of a novel elastase inhibitor from A. nidulans（Asnidin） . Asnidin is the first reported isolation of an elastase inhibitor from A. nidulans.
MATERIALS AND METHODS
Production of elastase inhibitor A sufficient number of A. nidulans NBRC 4340 （National Institute of Technology and Evaluation Biological Resource Center）spores were cultured in 100 ml synthetic medium of 0. 1% yeast carbon base（Difco Lab., Detroit, MI, USA）con-taining 1% casamino acid as a nitrogen source. The cultures were incubated for 7 days at 37℃ without shaking. The culture broth was filtered aseptically through a 0.22μm pore size membrane filter, and the cell-free culture supernatant was used as the source of crude inhibitor. Assay for elastase inhibitory activity Fifty microliters of elastase inhibitor solution was mixed with 50μl of the purified elastase from A. fumigatus 2） or A. flavus 8） and incubated for 15 min at 37℃ prior to the addition of the Glt-Ala-AlaPro-Leu-pNA（GAAPLNA） （Peptide Institute Inc. Osaka, Japan）substrate. Then 0. 9 ml of 50 mM Tris-HCl buffer, pH 7. 5, and 20μl of 50mM GAA-PLNA solution were added and incubated for 60 min at 37℃. The reaction was stopped by adding 1 ml of 10% trichloroacetic acid（TCA） . Then 0.2 ml of 0.1% sodium nitrate, 0.5% ammonium sulfamate, and 0. 1% N-1-naphthylethylenediamine dihydrochloride were added to the solution and the color that developed was read at 550 nm.
Amino acid sequence analysis
The amino acid sequence of Asnidin was analyzed by an Applied Biosystems 491 protein sequencer. The phenylthiohydantoin（PTH）de-rivatives of amino acids were identified with an Applied Biosystems Model 120A PTH analyzer in accordance with the manufacturer s instructions.
Assay for carbohydrate content
The carbohydrate content was assayed using glucose as a standard by the method of Morris 23） .
Heat and pH stabilities of Asnidin
The heat stability of Asnidin（0. 2 μ g）was investigated using 10 mM Tris-HCl buffer（pH 7. 5） containing 10 mM NaCl. The inhibitor was heated for 10 min at 37℃, 50℃, 60℃, 80℃, and 100℃ and then cooled quickly to 4℃, and the inhibitory activity was determined.
Asnidin（0.2μg）was incubated at 4℃ for 24 hr in buffers at various pH values（100 mM citrate buffer, pH 3; 100 mM acetate buffer, pH 5, 6; 100 mM Tris-HCl buffer, pH 7, 8, 9; 100 mM sodium hydrogen carbonate buffer, pH 12）and the inhibitory activity was determined.
RESULTS

Purification of Asnidin
Elastase inhibitory activity of the culture supernatant was measured, and the culture broth was filtered, and the cell-free culture supernatant was dialyzed against 10 mM Tris-HCl buffer（pH 7. 2） containing 10 mM NaCl. The dialysis residue was applied on a DE52-Cellulose equilibrated with 10 mM Tris-HCl buffer （pH 7.2） containing 10 mM NaCl. The column was eluted with equilibration buffer and 10 mM Tris-HCl buffer（pH 7.2）containing a 500 mM NaCl gradient（Fig. 1） . Inhibitory activity （90~100%）was found in fraction numbers 168~174. The fraction numbers 168~174 were pooled and analyzed using reversed-phase HPLC（Fig. 2） . The novel A. nidulans elastase inhibitor, Asnidin, was homogeneous as demonstrated by reversedphase HPLC. The yield from this purification procedure was 30 μ g of Asnidin from 100 ml of broth.
Properties of Asnidin
The molecular weight of Asnidin was 4,181.63 as determined by TOF-MS（Fig. 3） . Asnidin was found not to contain any carbohydrates, and was stable under heat treatment（the inhibitor remained 100% active at 100℃）and over the pH range of 3-12.
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The effects of the inhibitors DTT, EDTA and benzamidine on the elastolytic inhibitory activity of Asnidin were also determined. Asnidin was mixed with the inhibitors and incubated for 15 min at 37℃ prior to the addition of GAPPLNA as substrate to determine the elastolytic inhibitory activity. The inhibitor DTT inhibited about 100% of the elastolytic inhibitory activity of Asnidin; on the other hand, EDTA and benzamidine did not show any inhibitory effect on the elastolytic inhibitory activity.
The effects of Asnidin on the activities of various elastases were determined and are shown in Table 1 . Asnidin inhibited 99. 6%, 99. 2% and 97. 3% of the activities of elastases from A. fumigatus, A. flavus and human leukocytes but not chymotrypsin, and elastases from snake venom （rubelase） 24） and Pseudomonas aeruginosa were not inhibited by Asnidin. The porcine pancreas elastase inhibitory activities of Asnidin and AFUEI were 71. 4% and 11. 7%, respectively. This result suggests that the property of Asnidin is different from AFUEI greatly. The effects of Asnidin on human fibrinogenase and type IV collagen hydrolytic activities of elastase from A. fumigatus were studied according to the method of Okumura et al. 22） and Ouyang and Teng 26） . Both activities were completely inhibited by this inhibitor. 
Partial amino acid sequence of Asnidin
Partial amino acid sequence of Asnidin was identified（Fig. 4） . Interestingly, the search for amino acid homology with other proteins showed that amino acid residues 1 to 27 of Asnidin are 100% identical to residues 140 to 166 of the cell wall cysteine-rich protein（which contains 291 amino acid residues）in A. nidulans.
Comparison with other protease inhibitors
Inhibitory activity was compared with four other protease inhibitors（Table 2） . Ulinastatin, nafamostat mesilate, sivelestat sodium hydrate, and gabexate mesilate are reagents normally used in hospitals. Asnidin inhibited elastase from A. fumigatus. In comparison with the other inhibitors, elastase from A. fumigatus was inhibited by sivelestat sodium hydrate and gabexate mesilate. These results clearly demonstrated that elastase from A. fumigatus was inhibited by very small amounts of Asnidin, while the other four protease inhibitors showed very weak inhibitory activity compared with Asnidin. The effect of Asnidin on human leukocytes elastase was determined. The 50% inhibition against human leukocytes elastase was 0. 29μg for AFUEI 22） and 0. 14μg for Asnidin which was one-half of the concentration of AFUEI.
DISCUSSION
In a previous report, screening of the elastase inhibitor from Aspergillus was examined 18） with the finding that A. fumigatus and A. flavus did indeed produce an elastase inhibitor, and isolated respective elastase inhibitors from these Aspergillus strains 19−22） . We consider that elastase inhibitor produced in the culture medium produces inhibitors to block the damaging actions of elastase to itself. In this report, the isolation and characterization of a novel elastase inhibitor from A. nidulans are described. Compared with AFUEI（MW: 7525.8） 22） （A. fumigatus elastase inhibitor） , the molecular weight of Asnidin（MW: 4181. 63）is smaller and Asnidin is more heat stable. However, AFUEI was labile to heat treatment（the inhibitor remained 20% active at 80℃） . The elastolytic activities of elastases from A. fumigatus, A. flavus, and human leukocytes were inhibited by Asnidin to the same extent as AFUEI. On the other hand, partial amino acid sequence was determined, and 27 residues were determined from N-terminal. Assuming that the unidentified X of the partial sequence of Asnidin is cysteine, this partial sequence would agree with the residues 140~166（MW: 4184.69）of contains 2 cysteine residues while Asnidin has 6 cysteine residues. As compared with AFUEI, the primary structure of Asnidin differs greatly and homology is not observed at all. Since these molecular weights agree with that of Asnidin（4, 181.63） , Asnidin is considered to be a part of the cell wall cysteine-rich protein of A. nidulans ANIA08544. From this, there is a possibility that Asnidin is secreted into the culture fluid after cell wall components are decomposed by the enzyme. Ogawa et al. 28） reported a clinical effect with a protease inhibitor. When Aspergillus invades the body, it needs nutrients to live, therefore Aspergillus is thought to produce a strong elastase, which breaks human tissue and supplies nutrients. Development of Aspergillus weakens the body; however, if this could be controlled, an improved therapeutic effect should be obtained. Asnidin has a high selectivity, a molecular weight of 4,181.63, is heat and pH stable, and as stated above possesses sufficient potency to intervene in the pathogenic process of aspergillosis. Development of the material which inhibits leucocyte elastase for the purpose of suppressing internal inflammation is the present focus. For example, ONO-5046 29） is used for the treatment of acute lung disturbance with a general inflammatory reaction symptom-complex. In the future we plan to examine Asnidin in more detail by studying it in vivo and focusing on the possibility of Asnidin becoming another drug in the arsenal of weapons against aspergillosis or interstitial pneumonia.
